IMAX
IMAX Corporation
IMAX has the edge over META overall, supported by stronger fundamentals and stronger valuation.
META
Meta Platforms, Inc.
META trails on the overall score without a compensating advantage in the available component scores.
IMAX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
IMAX's revenue, profitability, cash flow and balance sheet are all currently strong.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
IMAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 21x | $47.89 | — |
| Forward | 24x | $47.89 | — |
| Cheap | 35x | $81.28 | +70% |
| Fair | 53x | $122 | +154% |
| Expensive | 62x | $144 | +202% |
Historical ranges are pointers, not guarantees.
IMAX has the edge over META in the historical PE scenario, which offers more potential upside but is not a forecast.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
IMAX Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect IMAX's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
IMAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.01 | -13% |
| Q3 2026 | $2.32 | +231% |
| Q2 2026 | $0.73 | +24% |
| Q1 2026 | $0.66 | +43% |
| Q4 2025 | $0.63 | +31% |
| Q3 2025 | $0.70 | +59% |
| Q2 2025 | $0.59 | +47% |
| Q1 2025 | $0.46 | -4.2% |
| Q4 2024 | $0.48 | +4.3% |
IMAX has the edge over META on earnings, with more consistent year-over-year improvement.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META earned $29.32 per share over the past year, up 30% from the year before.
IMAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $174.6M | +64% |
| Q2 2026 | $102.8M | +12% |
| Q1 2026 | $81.4M | -6.1% |
| Q4 2025 | $125.2M | +35% |
| Q3 2025 | $106.7M | +17% |
| Q2 2025 | $91.7M | +3.1% |
| Q1 2025 | $86.7M | +9.5% |
| Q4 2024 | $92.7M | +7.7% |
IMAX's revenue is growing: $175M last quarter, up 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 43% | +16 points |
| Q2 2026 | 20% | +4.5 points |
| Q1 2026 | 12% | -7.1 points |
| Q4 2025 | 19% | +9 points |
| Q3 2025 | 27% | +6 points |
| Q2 2025 | 16% | +12 points |
| Q1 2025 | 19% | +4.1 points |
| Q4 2024 | 10% | +7.1 points |
IMAX has the edge over META on profitability, with a higher operating margin.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over IMAX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META's operating margin was 20% last quarter, down 20 points from the same quarter a year ago, near the bottom of its range since 2019.
IMAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $84.2M | +30% |
| Q2 2026 | $32M | +53% |
| Q1 2026 | $1.9M | -64% |
| Q4 2025 | $28M | +307% |
| Q3 2025 | $64.8M | +90% |
| Q2 2025 | $20.9M | -38% |
| Q1 2025 | $5.3M | +$17.4M |
| Q4 2024 | $6.9M | +11958% |
IMAX has the edge over META on cash flow, with more consistent year-over-year improvement.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $28.6B over the past year.
IMAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.5% | +1.4M shares |
| 1 year | +4.4% | +2.4M shares |
| 3 years | +4.5% | +2.5M shares |
| 5 years | -2.3% | -1.4M shares |
| Available history | -5.7% | -3.5M shares |
IMAX has 58M diluted shares, up 4.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q3 2024 | — |
| Q2 2024 | $246,000 |
| Q1 2024 | $17.9M |
| Q3 2023 | $252,000 |
| Q2 2023 | $355,000 |
| Q1 2023 | $3.7M |
| Q4 2021 | $9.3M |
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over IMAX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
IMAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
IMAX has the edge over META on leverage, with a lower net debt burden relative to earnings.
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META's net debt is less than a year of its operating earnings (EBITDA).
IMAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 24.2 | Neutral |
IMAX's weekly RSI is 51 (neutral) and its Stochastic is 24 (neutral).
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
IMAX PE vs Communication Services Sector
| Metric | IMAX | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 25% above |
| PE % | 5 | 26 | 21 pts below |
IMAX has the edge over META on valuation relative to its sector.
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META is trading at 21x earnings, a 29% premium to the Communication Services sector's median of 16x.
IMAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.2 | 6.5% below |
| 20 week MA | $49.0 | 2.2% below |
| 50 week MA | $42.2 | 13% above |
| 100 week MA | $35.0 | 37% above |
| 200 week MA | $26.6 | 80% above |
IMAX has the edge over META on trend strength, trading above more of its moving averages.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
IMAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.8 | $17.0 | -18% |
| 2021 | $17.0 | $18.4 | +8.1% |
| 2022 | $18.4 | $14.0 | -24% |
| 2023 | $14.0 | $15.0 | +7.6% |
| 2024 | $15.0 | $25.1 | +67% |
| 2025 | $25.1 | $37.7 | +50% |
| 2026 YTD | $37.7 | $47.9 | +27% |
IMAX has the edge over META on returns for 2026, with the stronger performance.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.